Brown Rudnick advised Aerovate Therapeutics Inc. on the deal.Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the…
Aerovate Therapeutics’ IPO


Brown Rudnick advised Aerovate Therapeutics Inc. on the deal.Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the…
…